Cytos Cuts 80 Pct. of Jobs; Roche to Invest $200M for Research Center - Aug. 17, 2011

Having trouble viewing this email? View in Browser.

Wednesday, August 17, 2011  |   |   |   |  Pharm-Olam International Acquires StatWorks, Inc. With Pharm-Olam's acquisition of StatWorks we have expanded our team Data Management and Biostatistics experts for functional outsourcing and full service clinical trials. Our comprehensive biometric services include: • Integration of randomization into EDC systems, eliminating IVRS costs, with added benefit of full inventory control over supplies • Adaptive, Sequential, and Bayesian design methods • CDISC, SDTM and ADaM datasets • SAS programming, eCRF design, and medical coding in MedDRA/WHO Drug • Streamlining and reconciling across SAE, CTMS, and study DB • Health Outcomes Research and Patient Reported Outcomes • Protocol development, sample size, and randomization Contact us for your resource planning at www.pharm-olam.com, info@pharm-olam.com, USA 1-713-559-7900, UK 44-0-1344-891121   •  Cytos Biotechnology AG Cuts 80% of Jobs, Halts All in House Programs Except Lead Allergy Drug More... •  Roche (RHHBY) to Invest $200 Million for New Research Center, Creating 200 Jobs More... •  FDA Approves Roche (RHHBY)'s Skin Cancer Drug Zelboraf More... •  Regeneron Pharmaceuticals, Inc. (REGN) Falls on FDA Delay of Eye Drug More... •  Paladin Labs Inc. (CC:PLB) to Buy Labopharm Inc. (DDS.TO) for $20.5 Million More... •  Zogenix, Inc. Reports Positive Phase 3 Results for Zohydro - Meets Primary Efficacy Endpoint More... •  Protalix Biotherapeutics, Inc. (PLX) Announces FDA Accepts for Review Complete Response Resubmission for Taliglucerase Alfa and Assigns PDUFA Date More... •  Xcelience's Expansion Plans to Generate 45 More Jobs in Florida More... More Top News Sept. 15, 2011 - BayBio Life Science Series Venture Spotlight | Planning for Exit A panel of seasoned VC investors and life science executives who have recently navigated a successful exit will discuss the current state of the life science M&A and IPO markets and the tradeoffs between the two, when and how companies and investors should evaluate exit opportunities, key deal terms that are heavily negotiated in exit transactions and the venture capitalists' role in the exit process. Please click here for more information. •  Fired IT Staff Created Virtual Chaos At Pharma Company More... •  Fatty Diet Triggers Diabetes Onslaught, University of California, Santa Barbara Study More... •  Experts Redesign Common Microbe to Fight Drug-Resistant Bacteria, Nanyang Technological University Study More... •  New Drug May Relieve Severe, Tough-to-Treat Gout, University of Chicago Study More... •  Shedding Light On Antibiotic Resistance Via Realistic Simulation Of Ion Flux Through Membrane, Max Planck Institute Study More... •  Five Inherited Genetic Variants Linked to the Most Lethal Prostate Cancers, Fred Hutchinson Cancer Research Center Study More... •  Blood Injections May Help Chronic "Tennis Elbow", Henry Dunant Hospital Study More... •  Brain Cells Protect Themselves Against Stroke, University of Bristol Study More...   More Featured News Biomarker Applications for Improved Clinical Trial Outcomes November 15 - 16, 2011 Hilton Boston Back Bay - 40 Dalton Street The only personalized medicine conference allowing you to make biomarkers and diagnostics available during every stage of clinical research, to stratify patients, prove clinical validity, and streamline the regulatory approval and reimbursement process. Featuring up-to-date analysis of new FDA legislation regulations and a special spotlight from Blue Cross Blue Shield. For more information, please visit here. Drug Discovery Collaborations between Academia and the Pharmaceutical Industry • Understand the types of collaboration between academia and the biopharmaceutical industry, the cultural issues, and organizational conflicts. • Review the international and national legislation governing intellectual property rights for technology owners and transfer partners. • Gain insight into the evolving nature of industry-academic collaborations and the emerging opportunities for collaborative models of drug discovery. • Identify the various emerging quasi institutions, such as research clusters, that take advantage of developments in communication technologies. Click Here for More Information Nature Methods Nature Methods provides techniques for life scientists and chemists. It is a print and online publication dedicated to publishing novel methods together with significant advances to tried and tested techniques allowing researchers to perform faster, better and more efficient experimental research. Request Now! • BioCapital (Blacksburg, Virginia) Intrexon Corporation Scientist, Process Development Responsible for laboratory troubleshooting activities, process improvements, and other activities to support scale-up efforts in the UltraVector Division of Intrexon Corporation. This individual will interface with the DNA Vector Architecting, Vector Production, Vector Validation, Software Development, Laboratory Automation groups, and other Process Development team members to support the divisions DNA vector production objectives, etc. • Pharm Country (New York City, New York) ImClone Systems Corporation Research Associate(00898446) Assist in antibody discovery using phage display technology in a highly collaborative team within the Antibody Technology Department. Responsibilities of the successful candidate will include antibody selection and characterization using various molecular, biochemical/immuno and cell biological assay methods, etc. • Bio NC (Durham, North Carolina) Eisai Inc. Principle Process Engineer, Technical Operations This position applies process engineering and critical solid dose process knowledge to (1) solve solid dose process problems, (2) identify solid dose process requirements for new processes and technical operations projects, (3) manage technical operations projects and (4) provide input into technical operations and manufacturing procedures. • Genetown (Cambridge, Massachusetts) Broad Institute Research Associate II - Epigenomics Applies technical knowledge and practical skills in molecular biology to execute laboratory projects that support the overall research goals of the Epigenome Initiative. Consults with supervisor and other research staff on priorities and methods, etc. • BioForest (Vancouver, Canada) Cardiome Pharma Corp. Research Associate I, Biology Performs general maintenance duties in the laboratories. Develops and maintains cell cultures. Carries out basic molecular biology and biochemistry. Exercises technical discretion in execution and interpretation of experiments and protocols, etc. Get Noticed! Add your resume to the BioSpace Career Center! See more than 5,000 job postings in the BioSpace Career Center! Biotech Beach Career Fair Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Southern California region. Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.) Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research. Job seekers may register here. • Biotech Beach Career Fair, San Diego, CA September 22, 2011 • BioMidwest Career Fair, Chicago, IL October 4, 2011 • Pharm Country Career Fair, Bridgewater, NJ October 5, 2011 • Biotech Bay Career Fair, Burlingame, CA October 11, 2011 • Bio NC Career Fair, Durham, NC October 20, 2011 • BioCapital Beach Career Fair, Bethesda, MD November 1, 2011 • Genetown Career Fair, Cambridge, MA November 7, 2011 More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services PharmaCore, Inc. 4180 Mendenhall Oaks Parkway Suite 160 High Point, North Carolina 27265 U.S.A. Phone: 336-841-5250 Fax: 336-841-5251 PharmaCore, Inc. is a contract research organization with expertise in custom organic synthesis, cGMP scale-up, chemical process research and development, GMP analytical services, and medicinal chemistry services. For projects requiring long-term research and support, PharmaCore offers full time equivalent (FTE) contracts to maximize resources. More Company Profiles FREE Subscription to Clinical Laboratory International (CLI) Clinical Laboratory International (CLI) is the leading clinical lab magazine internationally and is crammed with information of direct relevance to everyone working in clinical and blood bank laboratories. Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship BioSpace Inc. 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 BioSpace Inc. 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the BioSpace News Beat Team. Editor & Publisher: Rosemary Do Editorial & Production Staff: Lana Ho, Suvarna Sheth, Matt Thwin, Maysa Darwish BioSpace.com - Life. Science. Community. • BioSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2011 BioSpace http://www.biospace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here. Safely unsubscribe from Biospace.com e-mail at any time by managing your account here.